Compounds such as 2-[(1-hydroxy-2-oxo-2phenylethyl) sulfanyl] acetic acid (3) (cmp-3) and 4-{[(furan-2-yl)-methyl] amino}-1,2-diazinane-3,6-dione (6) (cmp-6) have been identified as ALKBH5 inhibitors as well, significantly suppressing cancer progression [114]. The gene discussed is ALKBH5; the disease is cancer.